HRT Financial’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.08M Sell
94,701
-134,743
-59% -$2.71M ﹤0.01% 1832
2026
Q2
$4.71M Buy
229,444
+182,996
+394% +$3.1M 0.01% 1180
2026
Q1
$738K Sell
46,448
-77,775
-63% -$1.69M ﹤0.01% 2246
2025
Q4
$3.26M Buy
124,223
+17,939
+17% +$465K 0.01% 995
2025
Q3
$2.4M Buy
106,284
+6,796
+7% +$140K 0.01% 1046
2025
Q2
$1.98M Sell
99,488
-72,188
-42% -$1.41M 0.01% 933
2025
Q1
$2.9M Buy
171,676
+129,469
+307% +$2.21M 0.02% 656
2024
Q4
$779K Buy
42,207
+13,789
+49% +$269K ﹤0.01% 1211
2024
Q3
$617K Buy
+28,418
New +$635K ﹤0.01% 1488
2023
Q3
– Sell
-5,630
Closed -$208K – 2620
2023
Q2
$208K Sell
5,630
-29,807
-84% -$1.04M ﹤0.01% 1823
2023
Q1
$1.11M Buy
35,437
+6,867
+24% +$221K 0.01% 896
2022
Q4
$850K Buy
+28,570
New +$1.02M 0.01% 1060

Other funds holding FLGT

HRT Financial's FLGT Position: Q3 2026 in Review

HRT Financial reduced its Fulgent Genetics (FLGT) stake by 59% in Q3 2026, selling an estimated $2.71M and leaving 94,701 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

HRT Financial first reported a position in FLGT in Q4 2022 and has held it in 12 quarters since. The position peaked at $4.71M in Q2 2026. 134 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • HRT Financial held 94,701 shares of Fulgent Genetics worth $2.08M as of Q3 2026.
  • HRT Financial sold 134,743 Fulgent Genetics shares in Q3 2026, an estimated $2.71M.
  • Fulgent Genetics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #1832 holding.
  • HRT Financial first reported a position in Fulgent Genetics in Q4 2022 and has held it in 12 quarters since.
  • HRT Financial's Fulgent Genetics position peaked at $4.71M in Q2 2026.
  • 134 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.